Anti-TFPI Recombinant Antibody (Concizumab)

CAT#: TAB-734

Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.

Gene Expression
Figure 1 IHC staining of human smooth muscle Figure 2 IHC staining of human colon Figure 3 Cerebral cortex Figure 4 Colon Figure 5 Testis Figure 6 Placenta Figure 7 RNA cell line category: Cell line enhanced (HHSteC, HUVEC TERT2, LHCN-M2, TIME)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • undefined
  • Derivation
  • Humanized
  • Type
  • IgG4 - kappa
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IP, FC, FuncS, Neut, IF, WB, PK
  • Generic Name
  • concizumab
  • Related Disease
  • Hemophilia

Product Property

  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at -20°C. Avoid multiple freeze/thaw cycles.

Applications

  • Application Notes
  • The TFPI antibody has been reported in applications of ELISA, IP, FC, FuncS, Neut, IF, WB, PK.

Target

  • Alternative Names
  • concizumab;mAb 2021;4F110 ;TFPI;tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor);LACI;tissue factor pathway inhibitor;EPI;extrinsic pathway inhibitor;TFI;TFPI1;anti-convertin;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-734. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Versatile Application Possibilities
The versatility of Concizumab is notable; it performs well across a variety of applications, including WB, ELISA, and flow cytometry. This flexibility has allowed us to use the same antibody in multiple settings, reducing the need for different reagents.
Breast cancer biomarkers at key points during disease progression
Invaluable in Hemophilia Research
As hemophilia researchers, Concizumab has supported our investigations into clotting pathways as a reliable tool to study the effects of TFPI inhibition, which enables us to reveal new therapeutic possibilities.
Breast cancer biomarkers at key points during disease progression
Excellent Technical Support
The support provided by Creative Biolabs has been excellent. Their readiness to assist with technical questions ensures smooth experimental setups and optimal antibody performance.

Q&As

  1. What applications can Concizumab be used in?

    A: Concizumab is versatile and can be used in various applications, including ELISA, immunoprecipitation (IP), flow cytometry (FC), functional studies (FuncS), neutralization (Neut), immunofluorescence (IF), and Western blot (WB).

  2. How does Concizumab function in research?

    A: Concizumab is a monoclonal IgG4 antibody. It binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI, pQAenting its interaction with the active site of factor Xa (FXa), thus effectively modulating the coagulation process in study settings.

  3. How should Concizumab be stored for optimal activity?

    A: Store Concizumab at -20°C to maintain its stability and efficacy. It's important to avoid multiple freeze-thaw cycles to preserve its integrity.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Concizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Concizumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Concizumab"

Afuco™ Anti-TFPI ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-734)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human TFPI. It is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.
DrugMonitor™ Anti-Concizumab Antibody (VS-1224-YC301)
Concizumab has participated in trials for treating hemophilia A and congenital bleeding disorders. The DrugMonitor™ Anti-Concizumab Antibody (VS-1224-YC301) is an anti-drug antibody (ADA) against Concizumab. This drug-based antibody is raised in mice immunized with the Concizumab. The anti-Concizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Concizumab in samples.

See other products for "TFPI"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOR-3547 Rabbit Anti-TFPI Recombinant Antibody (clone DS3547AB) WB Rabbit IgG
CAT Product Name Application Type
AFC-TAB-734 Afuco™ Anti-TFPI ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-734) ELISA, IP, FC, FuncS, Neut, IF ADCC enhanced antibody
CAT Product Name Application Type
VS-0724-YC647 AbPlus™ Anti-TFPI Magnetic Beads (VS-0724-YC647) IP, Protein Purification
CAT Product Name Application Type
VS-0425-FY189 Human Anti-TFPI (clone Concizumab) scFv-Fc Chimera ELISA, FC Human IgG4, scFv-Fc
CAT Product Name Application Type
VS-0525-XY7198 Anti-TFPI Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare